Emerging applications for ferumoxytol as a contrast agent in MRI.
about
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsA comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancerCurrent and potential imaging applications of ferumoxytol for magnetic resonance imaging.4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart diseasePositive contrast high-resolution 3D-cine imaging of the cardiovascular system in small animals using a UTE sequence and iron nanoparticles at 4.7, 7 and 9.4 T.Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling.Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.Monitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI.Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice.Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation.Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.Recent developments in colorectal imagingA Review of Clinical Translation of Inorganic Nanoparticles.Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T.Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterialsA comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.A Manganese Alternative to Gadolinium for MRI Contrast.Safety and technique of ferumoxytol administration for MRI.MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass AcquisitionsConsiderations for Imaging the Inferior Vena Cava (IVC) with/without IVC Filters.A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRIFerumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3TWhole-body MRI in pediatric patients with cancerCurrent innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer.Applications of nanoparticles for diagnosis and therapy of cancer.Experimental estimation and analysis of variance of the measured loss power of magnetic nanoparticles.Molecular Imaging in Nanotechnology and Theranostics.Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions.Imaging patients with renal impairment.What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection.Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis.Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.Status and trends in the development of clinical diagnostic agents.Cancer nanomedicine: progress, challenges and opportunities.Gadolinium-based contrast agents: A comprehensive risk assessment.Advances in the clinical translation of nanotechnology.
P2860
Q26744352-D3B97D4C-C380-46C6-B79B-5FA0C1770330Q27000180-BE3B11FC-99F0-4449-96D5-04BBD323A503Q30234702-0D555838-4852-4E68-95EE-FFD8DC3DCE68Q30400570-2E356AC3-CB8F-42D4-A634-A74DA1BA6906Q30656936-63CF0F31-123E-4FA3-A403-8965FDF3061DQ31121875-78EAA91B-95C7-4C13-80B1-65A8F2316894Q31133294-7B9B4DA3-3C76-4CDC-9B30-D7595FAA6E74Q32176092-F06D9126-F87A-4323-B56B-35ADB86811DCQ33610361-557D5C68-7069-482D-93FB-5858FF683909Q33710955-BB5093FB-0908-4CC4-8679-6EEAD1D8E05EQ33773319-B537224F-3904-49C1-A078-A1E35E3088F4Q34782793-A0A178F2-4E25-4448-B59F-DC75475AA970Q35967907-54146E50-6530-4100-A7D1-513E3700BCB1Q36059493-D0904731-DE5B-4DC2-841E-B52371C92709Q36287535-27708707-3E49-4CB1-B495-5447E5B3F1D9Q36301599-9B63F560-67A1-4021-9AC2-E63AD72F7471Q36609886-312854D5-B08D-4CF2-9C81-4B9B8A5F9DC1Q36862859-2FD5BA23-7ADD-40AD-A468-BC6275461350Q36867051-D35C828A-9DD4-4158-897D-12D51410EBCDQ36888994-8FB0FE89-ABEA-432B-AB92-355EAC08DEDCQ36911124-6BD54C06-7BFB-4EB1-8C48-C11C64B2F3D5Q36927735-066C5491-CDC3-4435-8B3E-EDB2981BC413Q37024507-7EBC19B2-05D8-4790-8B37-B19A7A15C449Q37025426-CC1A61D8-4B65-4E4B-94E4-D3AF448317E6Q37637025-3EA83CAB-5614-408E-815A-9E4A479800F4Q38295006-6F48C5D9-70BB-4396-B61B-CCC4C55867E5Q38477152-D895CB29-6C83-4EE7-8414-996639381F9CQ38656439-E8E3EDFF-A806-49EC-AC77-A5492472C4A2Q38738754-24DB2F03-521B-473D-83A6-393AA2E360F9Q38743614-01A7D190-DEEE-4766-B9A1-ADFD4F152F3EQ38789239-33A3B725-5A78-4348-B1BE-FC52E95F13ACQ38790910-0C33AAA8-49E9-4C85-A652-6C0C45CBBAA6Q38836090-A1F7107E-B274-4F4E-9214-B42B1FEA2DF1Q38853466-34D7E33C-CBA8-4E72-A493-EC862D9C6BFBQ38922703-187F18B0-FA78-43D2-878E-C38E0B894BF5Q38981471-5FA0A5DB-460E-49D4-99F9-D157CE8B98B2Q38995734-41C9A3C4-D11D-45FC-B71A-C8273304EE2BQ39005226-B4FF3F4F-CD0A-4D8A-8876-0ED4993268AFQ39022872-32C930B6-1F2A-4612-9BE8-B34840CA787BQ39130471-9BE090C7-53DC-447B-92CB-5EF2AF3C85EC
P2860
Emerging applications for ferumoxytol as a contrast agent in MRI.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging applications for ferumoxytol as a contrast agent in MRI.
@en
type
label
Emerging applications for ferumoxytol as a contrast agent in MRI.
@en
prefLabel
Emerging applications for ferumoxytol as a contrast agent in MRI.
@en
P2093
P2860
P356
P1476
Emerging applications for ferumoxytol as a contrast agent in MRI.
@en
P2093
Daniele Marin
Lubna Bhatti
Mustafa R Bashir
Rendon C Nelson
P2860
P304
P356
10.1002/JMRI.24691
P577
2014-06-30T00:00:00Z